ACER, E. Et Al. 2020. Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors. CUTANEOUS AND OCULAR TOXICOLOGY , vol.39, no.2 , 171.

ACER, E., KAYA ERDOĞAN, H., Canakci, N. Y., & SARAÇOĞLU, Z. N., (2020). Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors. CUTANEOUS AND OCULAR TOXICOLOGY , vol.39, no.2, 171.

ACER, ERSOY Et Al. "Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors," CUTANEOUS AND OCULAR TOXICOLOGY , vol.39, no.2, 171, 2020

ACER, ERSOY Et Al. "Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors." CUTANEOUS AND OCULAR TOXICOLOGY , vol.39, no.2, pp.171, 2020

ACER, E. Et Al. (2020) . "Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors." CUTANEOUS AND OCULAR TOXICOLOGY , vol.39, no.2, p.171.

@article{article, author={ERSOY ACER Et Al. }, title={Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors}, journal={CUTANEOUS AND OCULAR TOXICOLOGY}, year=2020, pages={171} }